Search results
Results from the Health.Zone Content Network
The United States Department of Health and Human Services ( HHS) is a cabinet-level executive branch department of the U.S. federal government created to protect the health of the U.S. people and providing essential human services. Its motto is "Improving the health, safety, and well-being of America". [3]
Website. www.hhs.gov. The United States secretary of health and human services is the head of the United States Department of Health and Human Services, and serves as the principal advisor to the president of the United States on all health matters. The secretary is a member of the United States Cabinet. The office was formerly Secretary of ...
The Biomedical Advanced Research and Development Authority ( BARDA )' is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza ...
Hyperglycemic hyperosmolar syndrome (HHS) is a potentially life threatening condition involving extremely high blood sugar (glucose) levels. When your blood sugar gets too high, the kidneys try to ...
nausea, vomiting, or stomachache. confusion, slurred speech, or weakness on one side of your body. Symptoms of DKA can include: frequent urination. extreme thirst. high blood sugar levels. high ...
The Office of the National Coordinator for Health Information Technology ( ONC) is a staff division of the Office of the Secretary, within the U.S. Department of Health and Human Services. ONC leads national health IT efforts, charged as the principal federal entity to coordinate nationwide efforts to implement and use the most advanced health ...
June 13, 2023 – A topical gel that may work faster than erectile dysfunction pills has been approved for over-the-counter use in the United States. The gel, which can help users get an erection ...
COVID-19 pandemic. The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. [1]